| 1G0-GlcNac |
|---|
| 2G1-GlcNac |
| 3G0 |
| 4Man5 |
| 5G0F |
| 6G1F-GlcNac |
| 7G1F |
| 8G1F' |
| 9G1FB |
| 10G2F |
| 11G2FB |
| 12Sialylated Glycan |
| 13Sialylated Glycan |
| 14Sialylated Glycan |
| 15Sialylated Glycan |
| 16Sialylated Glycan |
| 17Sialylated Glycan |
| 18Sialylated Glycan |
| 19Sialylated Glycan |
| 20Sialylated Glycan |
| 21Sialylated Glycan |
| 22Sialylated Glycan |
search
Applications
IntantPC Labeled N-Linked Glycans from Infliximab-dyyb on bioZen Glycan
25037
Separation Mode: HILIC
HILIC
Glycan
HPLC
Pharmaceutical/Biopharmaceutical
Therapeutic / Clinical
Therapeutic / Clinical
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 25037)
Column: |
Brand Name: bioZen |
Part No: |
Phase Name: Glycan |
System: Waters ACQUITY UPLC H-Class Waters ACQUITY UPLC H-Class |
Sample Note: Utilize bioZen N-Glycan Clean-Up microelution SPE 96well plate for sample preparation (Part No.: 8M-S009-NGA). |
Similar Applications
search
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide